Successful acceptance of adult liver allografts by intra-bone marrow-bone marrow transplantation

Stem Cells and Development

Volumn 17, Issue 4, 2008, Pages 629-639

  Okazaki, Satoshi ^a   Hisha, Hiroko ^a   Mizokami, Tomomi ^a   Takaki, Takashi ^a   Wang, Xiaoli ^a   Song, Changye ^a   Li, Qing ^a   Kato, Junko ^a   Kamiyama, Yasuo ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN ANTIBODY; COLECALCIFEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; CELL STRUCTURE; DONOR; KIDNEY; LIVER; LIVER GRAFT; MOUSE; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; LIVER; LIVER TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; TRANSPLANTATION, HOMOLOGOUS;

MUS;

EID: 51849147079     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0218     Document Type: Article

References (36)

1. Williams JW, SR Vera, TG Peters and S Van Voorst. (1986). Survival following hepatic transplantation in the cyclosporine era. Am Surg 52:291-293.
2. Collins RH. (1994). Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. Lancet 344:949.
3. The U.S. Multicenter FK506 Liver Study Group. (1994). A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331:1110-1115.
4. Wiesner RH. (1998). A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. Transplantation 66:493-499.
5. Graham RM. (1994). Cyclosporine: mechanisms of action and toxicity. Cleve Clin J Med 61:308-313.
6. Demetris AJ, JJ Fung, S Todo, J McCauley, A Jain, S Takaya, M Alessiani, K Abu-Elmagd, DH Van Thiel and TE Starzl. (1992). Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy - a clinicopathologic study of 96 patients. Transplantation 53:1056-1062.
7. Pratschke J, R Neuhaus, SG Tullius, S Jonas, WO Bechstein and P Neuhaus. (1998). Treatment of cyclosporinerelated adverse effects by conversion to tacrolimus after liver transplantation: long-term results. Transplant Proc 30:1419-1421.
8. Ebata H, I Oikawa and M Mito. (1985). Rejection of allogeneic hepatocytes and fetal hepatic tissue transplanted into the rat spleen. Transplantation 39:221-223.
9. Nakamura T, RA Good, R Yasumizu, S Inoue, MM Oo, Y Hamashima and S Ikehara. (1986). Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 83:4529-4532.
10. Yasumizu R, S Miyawaki, K Sugiura, T Nakamura, Y Ohnishi, RA Good, Y Hamashima and S Ikehara. (1990). Allogeneic bone marrow-plus-liver transplantation in the C57BL/KsJ spm/spm mouse, an animal model of Niemann-Pick disease. Transplantation 49:759-764.
11. Rhodes DF, WM Lee, JR Wingard, MD Pavy, GW Santos, BW Shaw, RP Wood, MF Sorrell and RS Markin. (1990). Orthotopic liver transplantation for graft-versushost disease following bone marrow transplantation. Gastroenterology 99:536-538.
12. Schlitt HJ, HJ Tischler, B Ringe, G Raddatz, H Maschek, H Dietrich, F Kuse, R Pichlmayer R and H Link. (1995). Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation - clinical and immunological considerations. Bone Marrow Transplant 16:473-478.
13. Urban CH, A Deutschmann, R Kerbl, H Lackner, W Schwinger, A Konigsrainer and R Margreiter. (2002). Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 30:535-537.
14. Andreoni KA, JI Lin and PA Groben. (2004). Liver transplantation 27 years after bone marrow transplantation from the same living donor. N Engl J Med 350:2624-2625.
15. Ringden O, G Soderdahl, J Mattsson, M Uzunel, M Remberger, P Hentschke, H Hagglund, E Sparrelid, A Elmhorn-Rosenborg, F Duraj, H Zetterquist and BG Ericzon. (2000). Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer. Transplantation 69:2043-2048.
16. Kushida T, M Inaba, H Hisha, N Ichioka, T Esumi, R Ogawa, H Iida and S Ikehara. (2001). Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97:3292-3299.
17. Zhang Y, Y Adachi, Y Suzuki, K Minamino, M Iwasaki, H Hisha, C Song, K Kusafuka, K Nakano, Y Koike, J Wang, E Koh, Y Cui, C Li and S Ikehara. (2004). Simultaneous injection of bone marrow cells and stromal cells into bone marrow accelerates hematopoiesis in vivo. Stem Cells 22:1256-1262.
18. Li Q, H Hisha, R Yasumizu, T Fan, G Yang, Q Li, Y Cui, X Wang, C Song, S Okazaki, T Mizokami, W Cui, K Guo, M Li, W Feng, J Katou and S Ikehara. (2007). Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes. Stem Cells 25:1186-1194.
19. Yahata T, K Ando, T Sato, H Miyatake, Y Nakamura, Y Muguruma, S Kato and T Hotta. (2003). A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101:2905-2913.
20. Taira M, M Inaba, K Takada, S Baba, J Fukui, Y Ueda, AH Kwon, H Hisha, Y Kamiyama and S Ikehara. (2005). Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 79:680-687.
21. Esumi T, M Inaba, N Ichioka, T Kushida, H Iida and S Ikehara. (2003). Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 76:1543-1548.
22. Guo K, M Inaba, M Li, J An, W Cui, C Song, J Wang, Y Cui, Y Sakaguchi, M Tsuda, M Omae, Y Ando, Q Li, X Wang, Feng W and S Ikehara. (2008). Long-term donor-specific tolerance in rat cardiac allografts by intra-bone marrow injection of donor bone marrow cells. Transplantation 85: 93-101.
23. Hisha H, T Nishino, M Kawamura, S Adachi and S Ikahara. (1995). Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 23:347-352.
24. Hosaka N, M Nose, M Kyogoku, N Nagata, S Miyashima, RA Good and S Ikehara. (1996). Thymus transplantation, a critical factor for correction of autoimmune diseases in aging MRL/+ mice. Proc Natl Acad Sci USA 93:8558-8562.
25. Iwai H, R Yasumizu, K Sugiura, M Inaba, T Kumazawa, RA Good and S Ikehara. (1987). Successful pancreatic allografts in combination with bone marrow transplantation in mice. Immunology 62:457-462.
26. Cui Y, H Hisha, G Yang, T Fan, T Jin, Q Li, Z Lian and S Ikehara. (2002). Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant 30:843-849.
27. Zhang Z, L Zhu, D Quan, B Garcia, N Ozcay, J Duff, C Stiller, A Lazarovits, D Grant and R Zhono. (1996). Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62:1267-1272.
28. Sun J, GW McCaughan, ND Gallagher, AGR Sheil and GA Bishop. (1995). Deletion of spontaneous rat liver acceptance by donor irradiation. Transplantation 60:233-236.
29. Wu W, N Zheng, Y Wang, J Fung, L Lu and S Qian. (2006). Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery 26:17-20.
30. Davies H, S Pollard and R Calne. (1989). Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47:524-527.
31. Moore KW, A O'Garra, R de Waal Malefyt, P Vieira and TR Mosmann. (1993). Interleukin-10. Annu Rev Immunol 11:165-190.
32. Morita Y, M Yamamoto, M Kawashima, T Aita, S Harada, H Okamoto, H Inoue and H Makino. (2001). Differential in vitro effects of IL-4, IL-10 and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synobium. Rheumatol Int 20:49-54.
33. Schmidt-Weber CB, SI Alexander, LE Henault, L James and AH Lichtman. (1999). IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J Immunol 162:238-244.
34. Oswald IP, RT Gazzinelli, A Sher and SL James. (1992). IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 148:3578-3582.
35. Sefrioui H, J Donahue, EA Gilpin, AS Srivastava and E Carrier. (2003). Tolerance and immunity following in utero transplantation of allogeneic fetal liver cells: the cytokine shift. Cell Transplant 12:75-82.
36. Chung SW, EM Yoshida, MS Cattral, Y Hu and RM Gorczynski. (1998). Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett 63:91-96.